Sumant Kulkarni

Work Rating Distribution Performance Price Targets & Ratings Chart

Analyst Sumant Kulkarni works at CANACCORD and is covering the the Healthcare sector with 247 price targets and ratings documented since 2012 spanning on 16 stocks.

Sumant Kulkarni's average stock forecast success ratio is 37.21% with an average time for price targets to be met of 191.38 days.

Most recent stock forecast was given on VYGR, Voyager Therapeutics, Inc at 10-May-2023.

Wall Street Analyst Sumant Kulkarni

Analyst best performing recommendations are on VYGR (VOYAGER THERAPEUTICS, INC).
The best stock recommendation documented was for BTAI (BIOXCEL THERAPEUTICS, INC) at 10/7/2019. The price target of $24 was fulfilled within 130 days with a profit of $17.54 (271.52%) receiving and performance score of 20.89.

Average potential price target upside

Currently, out of the existing stock ratings of Sumant Kulkarni - 8 which are a Buy (100%)

ACAD ATAI BHVN BIIB BTAI CRTX ITCI NBIX SAGE VYGR ZYNE CARA CMPS CYBN KMPH TEVA

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Hold

26

$2.03 (8.47%)

32

15 days ago

4/7 (57.14%)

$6.71 (26.73%)

285

Buy

28

$4.03 (16.81%)

28

28 days ago

5/10 (50%)

$9.79 (40.33%)

175

Buy

23

$-0.97 (-4.05%)

35

28 days ago

8/14 (57.14%)

$11.27 (50.83%)

188

Buy

27

$3.03 (12.64%)

27

28 days ago

3/15 (20%)

$9.76 (40.41%)

186

Hold

20

$-3.97 (-16.56%)

20

1 months 23 days ago

7/11 (63.64%)

$3.28 (11.66%)

51

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

To continue looking at which analysts cover the stock please register to the basic or advanced membership